Results 151 to 160 of about 19,216 (264)

Value of coronary computed tomography angiography-derived plaque multiparameter analysis for guiding the management of intermediate coronary stenosis. [PDF]

J Thorac Dis
Guo D, Zhu J, Wu G, Li H, Guan L, Yang J, Zhai X, Lv S.   +7 more
europepmc   +1 more source

Substitution of fiber hemp for corn did not affect soil greenhouse gas emissions from a Kentucky cropping system

Agrosystems, Geosciences &Environment, Volume 9, Issue 3, September 2026.
Abstract Industrial hemp's return to American agriculture has been accompanied by claims of the crop's carbon neutrality, primarily due to its commercial applications. While carbon can be sequestered within products made with hemp fiber, there is little empirical evidence quantifying greenhouse gas contributions from the crop's production.
Kent Pham, Rebecca K. McGrail, Luke A. Moe, Robert Pearce, Rebecca L. McCulley   +4 more
wiley   +1 more source

MRCA Combined With Zero-Contrast IVUS-Guided PCI in a Patient With NSTE-ACS and Severe Contrast Allergy. [PDF]

JACC Case Rep
Wang H, Wu Y, Jian Z, Luo Y.
europepmc   +1 more source

Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA

American Journal of Hematology, Volume 101, Issue 9, Page 2246-2257, September 2026.
ABSTRACT Frameshift mutations in exon 12 of nucleophosmin 1 (NPM1 mut) are among the most common mutations in acute myeloid leukemia (AML) and have historically been considered favorable‐risk in the absence of FLT3‐ITD. In the European LeukemiaNet (ELN) 2024 risk‐classification for patients treated with hypomethylating agents plus venetoclax (HMA + VEN)
Fieke W. Hoff, Joshua F. Zeidner, Geeta Torlapati, Deedra Nicolet, Krzysztof Mrózek, Ying Huang, Alexander Li, Rina Li Welkie, Ronan T. Swords, Elie Traer, Eytan M. Stein, Tara L. Lin, Maria R. Baer, Vu H. Duong, William G. Blum, Martha L. Arellano, Wendy Stock, Olatoyosi Odenike, Rebecca L. Olin, Catherine C. Smith, Gary J. Schiller, Emily K. Curran, Onyee Chan, Christine McMahon, Michael Hochman, Kieran Sahasrabudhe, Charles Foucar, Jesus Gonzalez‐Lugo, Brittany Knick Ragon, Shivani V. Handa, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja G. Marcus, Leonard Rosenberg, Brian J. Druker, Ross L. Levine, Amy Burd, Ashley O. Yocum, Uma M. Borate, Alice S. Mims, Ann‐Katrin Eisfeld, John C. Byrd, Yazan F. Madanat   +44 more
wiley   +1 more source

Research and Application of Multi-Link Aggregation Algorithm Based on Link Priority for Telemedicine in Complex Environments. [PDF]

Healthc Technol Lett
Wang R, Cao D, Ran J, Dong J, Ma J, Yang X, Li T, He K.   +7 more
europepmc   +1 more source

Ruxolitinib Pharmacokinetics and Exposure–Toxicity Relationship in Hematologic Malignancies and Immune‐Mediated Diseases: A Prospective Observational Study

Clinical Pharmacology &Therapeutics, Volume 120, Issue 3, Page 753-761, September 2026.
Ruxolitinib pharmacokinetics (PK) has been characterized in clinical trials but remains poorly documented in real‐world practice. This project aimed to investigate ruxolitinib PK in routine clinical practice, identify factors driving its variability, and explore exposure–response relationships to assess the potential role of therapeutic drug monitoring.
Jérémie Tachet, Sara C. Meyer, Francesco Grandoni, Emmanuel Haefliger, Monika Nagy‐Hulliger, Jörg P. Halter, Jakob R. Passweg, David Haefliger, Carine Bardinet, Laurent A. Decosterd, Monia Guidi, François R. Girardin   +11 more
wiley   +1 more source

Efficacy and safety of ALA/MLA photodynamic therapy for superficial and nodular basal cell carcinoma: a systematic review and meta-analysis. [PDF]

Front Oncol
Jiang M, Li D, Huang Y, Zhang Q.
europepmc   +1 more source

Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP

The Laryngoscope, Volume 136, Issue S4, Page S7-S17, September 2026.
ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm ...
Simon R. Best, Aaron D. Friedman, Clark A. Rosen, Robert T. Sataloff, Laura A. Matrka, H. Steven Sims, David E. Rosow, Nabil F. Saba, David G. Lott, Adam M. Klein, Ted Mau, Milan R. Amin, Kathryn A. Wikenheiser‐Brokamp, Scott M. Norberg, Kim McClellan, Geoffrey D. Young, Clint T. Allen, on behalf of the Recurrent Respiratory Papillomatosis Foundation   +17 more
wiley   +1 more source

Last Call: mla 2018

Medienimpulse, 2018
Katharina Kaiser-Müller
doaj   +2 more sources

Invasive Right Anomalous Coronary Arteries Assessment: Intravascular Ultrasound and Adenosine vs Dobutamine Fractional Flow Reserve. [PDF]

JACC Adv
Stark AW, Ferroni A, Mathey-de-l'Endroit RL, Kakizaki R, Bigler MR, Biccirè FG, Ilic M, Shiri I, Haeberlin A, Siepe M, Windecker S, Räber L, Gräni C.   +12 more
europepmc   +1 more source